1. Home
  2. ENVB vs VNRX Comparison

ENVB vs VNRX Comparison

Compare ENVB & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

N/A

Current Price

$1.41

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.16

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENVB
VNRX
Founded
1994
N/A
Country
United States
United States
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.3M
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
ENVB
VNRX
Price
$1.41
$0.16
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $12.03
AVG Volume (30 Days)
27.5K
★ 1.8M
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $39,914,675.00
$1,727,384.00
Revenue This Year
N/A
$68.91
Revenue Next Year
N/A
$279.50
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 40.04
52 Week Low
$1.17
$0.13
52 Week High
$795.00
$3.26

Technical Indicators

Market Signals
Indicator
ENVB
VNRX
Relative Strength Index (RSI) 44.66 39.23
Support Level $1.35 $0.15
Resistance Level $1.55 $0.18
Average True Range (ATR) 0.09 0.02
MACD -0.00 0.00
Stochastic Oscillator 22.73 6.14

Price Performance

Historical Comparison
ENVB
VNRX

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: